Skip to main content
BrainCited

Folate için Nutritional Deficiency Cognitive Impairment

B

Critical for homocysteine metabolism and SAM production essential for neurotransmitter synthesis. MTHFR polymorphism carriers may benefit more from methylated forms (5-MTHF).

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dfolate\u0026condition\u003Dnutritional\u002Ddeficiency\u002Dcognitive'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Sonuç

Critical for homocysteine metabolism and SAM production essential for neurotransmitter synthesis. MTHFR polymorphism carriers may benefit more from methylated forms (5-MTHF).

Key Study Findings

Observational Study n=2582
Relationship Between Serum Vitamins and Cognitive Impairment in the Elderly: A Study Based on the …
Dose: None vs: None Outcome: Cognitive impairment risk Etki: OR=0.695 (Vit D); OR=0.777 (FA) p=0.003 (Vit D); p=0.034 (FA)

Popülasyon: Elderly participants aged 60+ from NHANES 2011-2014

Cross-Sectional Study n=1966
Folate mediates cognitive impairment of aged people with periodontitis.
Dose: None vs: Placebo Etki: Mediation proportion: dietary supplement folate 8.4%; serum total folate 9.1%; RBC folate 9.1% None
Review
B-vitamins and one-carbon metabolism during pregnancy: health impacts and challenges.
Dose: None vs: None Outcome: Pregnancy outcomes and offspring neurodevelopment Etki: None None

Popülasyon: Pregnant women (review)

Meta-Analysis
Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis.
Dose: None vs: Standard care or placebo Outcome: Global cognition in stroke survivors Etki: SMD=0.62 (energy-protein); SMD=-0.40 (B-vitamins) 0.009 (protein); 0.02 (B-vit)

Popülasyon: Adult stroke survivors (20 trials + 14 observational)

Other
Fresh Genetic Insights Into Micronutrients Influences on Restless Legs Syndrome Risk.
Dose: None vs: None Outcome: Causal association of micronutrients with RLS Etki: Retinol OR 0.46; Mg OR 0.62 None

Popülasyon: European ancestry (7248 RLS cases, 19802 controls)

Randomized Controlled Trial Double-blind
Relationships of B12 and Homocysteine with Outcomes in the SURE-PD, SURE-PD3, and STEADY-PDIII Trials.
Dose: Vitamin B12 (measured, not supplemented) vs: Within-trial comparison Outcome: B12/homocysteine association with PD outcomes Etki: None None

Popülasyon: Early Parkinson's disease patients

Key Statistics

10

Çalışmalar

1500

Katılımcılar

Positive

B

Derece

Referenced Papers

The Senior care … 2021 2 atıf
Journal of Alzheimer's … 2018 281 atıf
European journal of … 2012 225 atıf
Evidence report/technology assessment 2006
The Cochrane database … 2003 263 atıf
Current opinion in … 1998 30 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:
400 mcg DFE/day (RDA)
cognitivesupport:
400-800 mcg/day

Üst sınır: 1,000 mcg/day from supplements (may mask B12 deficiency)

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
None -- Positive 2582
None -- Positive 1966
None -- Positive --
None -- Mixed --
None -- Mixed --
Vitamin B12 (measured, not supplemented) -- Positive --
None -- Positive --
>5 mg/day -- Negative --

En iyi alım zamanı: With or without food; morning preferred

Safety & Side Effects

Bildirilen Yan Etkiler

  • Generally well-tolerated
  • May mask B12 deficiency symptoms
  • Rare: insomnia or irritability at high doses

Bilinen Etkileşimler

  • Methotrexate (antagonist — folate reduces efficacy)
  • Anticonvulsants (phenytoin, carbamazepine — mutual interference)
  • Sulfasalazine (reduces folate absorption)

Tolere edilebilir üst alım: 1,000 mcg/day from supplements (may mask B12 deficiency)

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Folate help with Nutritional Deficiency Cognitive Impairment?
Based on 10 studies with 1,500 participants, there is moderate evidence from clinical studies that Folate may support Nutritional Deficiency Cognitive Impairment management. Our evidence grade is B (Good Evidence).
How much Folate should I take for Nutritional Deficiency Cognitive Impairment?
Studies have used various dosages. A commonly studied range is 400 mcg DFE/day (RDA). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Folate?
Reported side effects may include Generally well-tolerated, May mask B12 deficiency symptoms, Rare: insomnia or irritability at high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Folate and Nutritional Deficiency Cognitive Impairment?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 1,500 total participants. The overall direction of effect is positive.

Related Evidence

Şu durum için diğer içerikler: Nutritional Deficiency Cognitive Impairment

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.